Preclinical evaluation of dasatinib in melanoma cell lines

被引：0
|
作者：
Eustace, A. J. [1 ]
Crown, J. [2 ]
Clynes, M. [1 ]
O'Donovan, N. [1 ]
机构：
[1] Dublin City Univ, Natl Insititute Cellular Biotechnol, Dublin 9, Ireland
[2] St Vincents Hosp Dublin 4, Dept Oncol, Dublin, Ireland
来源：
EJC SUPPLEMENTS | 2008年 / 6卷 / 09期
关键词：
D O I：
10.1016/S1359-6349(08)71602-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：112 / 112
页数：1
相关论文
共 50 条
  • [21] Evaluation of preclinical efficacy of everolimus and pasireotide in thyroid cancer cell lines and xenograft models
    Owonikoko, Taofeek K.
    Zhang, Guojing
    Lallani, Shenila B.
    Chen, Zhengjia
    Martinson, Deborah E.
    Khuri, Fadlo R.
    Lonial, Sagar
    Marcus, Adam
    Sun, Shi-Yong
    PLOS ONE, 2019, 14 (02):
  • [22] Preclinical evaluation of the AKT inhibitor MK-2206 in nasopharyngeal carcinoma cell lines
    Brigette B. Y. Ma
    Vivian W. Y. Lui
    Connie W. C. Hui
    Cecilia P. Y. Lau
    Chi-Hang Wong
    Edwin P. Hui
    Margaret H. Ng
    S. W. Tsao
    Yan Li
    Anthony T. C. Chan
    Investigational New Drugs, 2013, 31 : 567 - 575
  • [23] Development and evaluation of human AP endonuclease inhibitors in melanoma and glioma cell lines
    Mohammed, M. Z.
    Vyjayanti, V. N.
    Laughton, C. A.
    Dekker, L. V.
    Fischer, P. M.
    Wilson, D. M., III
    Abbotts, R.
    Shah, S.
    Patel, P. M.
    Hickson, I. D.
    Madhusudan, S.
    BRITISH JOURNAL OF CANCER, 2011, 104 (04) : 653 - 663
  • [24] Development and evaluation of human AP endonuclease inhibitors in melanoma and glioma cell lines
    M Z Mohammed
    V N Vyjayanti
    C A Laughton
    L V Dekker
    P M Fischer
    D M Wilson
    R Abbotts
    S Shah
    P M Patel
    I D Hickson
    S Madhusudan
    British Journal of Cancer, 2011, 104 : 653 - 663
  • [25] Evaluation of delayed apoptotic response in lethally irradiated human melanoma cell lines
    Tsoncheva, VL
    Kirov, KS
    Valkova, CA
    Milchev, GI
    ZEITSCHRIFT FUR NATURFORSCHUNG C-A JOURNAL OF BIOSCIENCES, 2001, 56 (7-8): : 660 - 665
  • [26] Establishment of novel cell lines recapitulating the genetic landscape of uveal melanoma and preclinical validation of mTOR as a therapeutic target
    Amirouchene-Angelozzi, Nabil
    Nemati, Fariba
    Gentien, David
    Nicolas, Andre
    Dumont, Amaury
    Carita, Guillaume
    Camonis, Jacques
    Desjardins, Laurence
    Cassoux, Nathalie
    Piperno-Neumann, Sophie
    Mariani, Pascale
    Sastre, Xavier
    Decaudin, Didier
    Roman-Roman, Sergio
    MOLECULAR ONCOLOGY, 2014, 8 (08) : 1508 - 1520
  • [27] Establishment of novel cell lines recapitulating the genetic landscape of uveal melanoma and preclinical validation of mTOR as a therapeutic target
    Amirouchene-Angelozzi, Nabil
    Nemati, Fariba
    Gentien, David
    Lepage, May-Linda
    Nicolas, Andre
    Madic, Jordan
    Dumont, Amaury
    Carita, Guillaume
    Camonis, Jaques
    Desjardins, Laurence
    Cassoux, Nathalie
    Piperno-Neumann, Sophie
    Mariani, Pascale
    Sastre, Xavier
    Decaudin, Didier
    Roman-Roman, Sergio
    CANCER RESEARCH, 2014, 74 (19)
  • [28] Validation of preclinical models of melanoma: tools for therapeutic evaluation
    Mourah, S.
    Varna, M.
    Sadoux, A.
    Yahiaoui, S.
    Podgorniak, M. P.
    Leclert, G.
    Pages, C.
    May, P.
    Marika, P.
    Soulier, J.
    Feugeas, J. P.
    Janin, A.
    Lebbe, C.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2014, 28 : 39 - 39
  • [29] Chemosensitivity of conjunctival melanoma cell lines
    Westekemper, H.
    Akguel, H.
    Scharifi, M.
    Anastassiou, G.
    Nareyeck, G.
    Freistuehler, M.
    Zeschnigk, M.
    Lohmann, D.
    Bornfeld, N.
    Steuhl, K. -P
    Scheulen, M. E.
    Hilger, R. A.
    ONKOLOGIE, 2010, 33 : 66 - 66
  • [30] Genetic analyses of melanoma cell lines
    Ogbah, Z.
    Simonetta, F.
    Puig-Butille, J.
    Badenas, C.
    Malvehy, J.
    Benitez, D.
    Vilella, R.
    Puig, S.
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2007, 299 (5-6) : 293 - 293
12345